Trial intelligence / Profile preview

Intraperitoneal ropivacaine alone vs with dexmedetomidine or fentanyl for postoperative pain after elective abdominal laparoscopy

IRCT20141209020258N117Phase 3Completed

Sponsor
Arak University of Medical Sciences
Start
Jan 2019
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial in postoperative pain comparing Intraperitoneal ropivacaine alone, Intraperitoneal ropivacaine + dexmedetomidine and Intraperitoneal ropivacaine + fentanyl (3 arms). Primary endpoint: postoperative pain intensity. Started Jan 2019; status: completed.

02

Drugs

ropivacainedexmedetomidinefentanyl
03

Conditions

postoperative pain

Beyond the preview

Go deeper on IRCT20141209020258N117.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20141209020258N117.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call